Skip to main content
Premium Trial:

Request an Annual Quote

Microbead Developer CyVera Becomes Subsidiary of Illumina

NEW YORK, April 12 (GenomeWeb News) - Illumina has completed its previously announced acquisition of microbead developer CyVera for $17.5 million in stock and cash, the company said yesterday.

 

Illumina acquired the Connecticut-based company for 1.6 million of its shares of common stock and $2.5 million in cash, which includes CyVera's liabilities. Illumina also assumed CyVera's outstanding stock options.

 

Illumina first announced in February that it intended to purchase CyVera, which is now a wholly owned Illumina subsidiary.

The Scan

NFTs for Genome Sharing

Nature News writes that non-fungible tokens could be a way for people to profit from sharing genomic data.

Wastewater Warning System

Time magazine writes that cities and college campuses are monitoring sewage for SARS-CoV-2, an approach officials hope lasts beyond COVID-19.

Networks to Boost Surveillance

Scientific American writes that new organizations and networks aim to improve the ability of developing countries to conduct SARS-CoV-2 genomic surveillance.

Genome Biology Papers on Gastric Cancer Epimutations, BUTTERFLY, GUNC Tool

In Genome Biology this week: recurrent epigenetic mutations in gastric cancer, correction tool for unique molecular identifier-based assays, and more.